IZOTROPIC CORP. (F:1R3) — Market Cap & Net Worth
Market Cap & Net Worth: IZOTROPIC CORP. (1R3)
IZOTROPIC CORP. (F:1R3) has a market capitalization of $9.91 Million (€8.47 Million) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #26906 globally and #2329 in its home market, demonstrating a 15.58% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IZOTROPIC CORP.'s stock price €0.18 by its total outstanding shares 68984679 (68.98 Million). Analyse 1R3 cash flow conversion to see how efficiently the company converts income to cash.
IZOTROPIC CORP. Market Cap History: 2019 to 2026
IZOTROPIC CORP.'s market capitalization history from 2019 to 2026. Data shows change from $10.57 Million to $14.36 Million (-2.02% CAGR).
IZOTROPIC CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IZOTROPIC CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1R3 by Market Capitalization
Companies near IZOTROPIC CORP. in the global market cap rankings as of May 2, 2026.
Key companies related to IZOTROPIC CORP. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
IZOTROPIC CORP. Historical Marketcap From 2019 to 2026
Between 2019 and today, IZOTROPIC CORP.'s market cap moved from $10.57 Million to $ 14.36 Million, with a yearly change of -2.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €14.36 Million | +11.95% |
| 2025 | €12.82 Million | +349.15% |
| 2024 | €2.86 Million | -49.72% |
| 2023 | €5.68 Million | -84.86% |
| 2022 | €37.50 Million | -23.27% |
| 2021 | €48.87 Million | -22.31% |
| 2020 | €62.91 Million | +495.42% |
| 2019 | €10.57 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of IZOTROPIC CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.91 Million USD |
| MoneyControl | $9.91 Million USD |
| MarketWatch | $9.91 Million USD |
| marketcap.company | $9.91 Million USD |
| Reuters | $9.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IZOTROPIC CORP.
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation … Read more